CompletedNot Applicable

Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic

1,179 participantsStarted 2015-01

Plain-language summary

Detection of the drug resistance molecular markers for falciparum and vivax in Longitudinal follow-up samples collected in Shwegyin Township, Bago Region that is Artemisinin Resistance Containment Tier I.

Who can participate

Age range6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Local resident in stud sites * Who give informed consent * No known tentative plan to move/ migrant elsewhere within one year Exclusion Criteria: * Migrant or mobile population * Less than 6 year

What they're measuring

Number of the Asymptomatic malaria infection

Timeframe: 2016 March

Trial details

NCT IDNCT02708199

SponsorDepartment of Medical Research, Lower Myanmar

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Increased Drug Resistance trials